US 5,843,970 A · Thiazolidine derivatives for the treatment of hypertension

Abstract

This invention relates to a second medical use of thiazolidine compounds having anti-diabetic properties. These compounds are also of use for the control of essential hypertension.

Claims1

Dependent claims

A method for controlling essential hypertension and its related cardiovascular syndrome in a mammal host in need thereof comprising administering an effective amount of the thiazolidine derivative 5-(4-2-(5-ethyl-2-pyridylethoxy!benzyl)-2,4-thiazolidine dione.

Dependencies are inferred from the claim text.

Facts

Application

07/725,327Filed 8 Jul 1991 · continuation in part

Priority

13 Oct 1989

Granted

1 Dec 1998

Term ends

Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof
A61K 31/425
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: thiazoles
A61K 31/426
Thiazoles: 1,3-Thiazoles
A61K 31/427
Thiazoles: not condensed and containing further heterocyclic rings

Abstract

This invention relates to a second medical use of thiazolidine compounds having anti-diabetic properties. These compounds are also of use for the control of essential hypertension.

Thiazolidine derivatives for the treatment of hypertension

Life of this patent

Abstract

Claims1

Thiazolidine derivatives for the treatment of hypertension

Life of this patent

Abstract

Claims1